FDA Adverse Event Injury Summary report: N

ACTIVA

MDR report key: 2872787 · Received December 13, 2012

Report

Report Number
3007566237-2012-03007
Event Type
Injury
Date Received
December 13, 2012
Date of Event
November 1, 2012
Report Date
November 16, 2012
Manufacturer
MEDTRONIC NEUROMODULATION
Product Code
MHY
PMA / PMN Number
P960009
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
SW
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

PRODUCT ID NEU_UNKNOWN_LEAD, SERIAL# UNKNOWN, PRODUCT TYPE LEAD. (B)(4). THE ACTUAL EVENT DATES WERE NOT PROVIDED. THIS DATE IS BASED ON THE DATE OF PUBLICATION OF THE ARTICLE. IT WAS NOT POSSIBLE TO ASCERTAIN SPECIFIC DEVICE INFORMATION FROM THE ARTICLE OR TO MATCH THE EVENTS REPORTED WITH PREVIOUSLY REPORTED EVENTS.

Description of Event or Problem · 1

ADDITIONAL INFORMATION: WITHIN A COUPLE OF MONTHS OF IMPLANT THE EFFECT ON TREMOR WAS VIRTUALLY LOST.

Description of Event or Problem · 1

BLOMSTEDT, P., LINDVALL, P., LINDER, J., OLIVECRONA, M., FORSGREN, L., HARIZ, M. I. REOPERATION AFTER FAILED DEEP BRAIN STIMULATION FOR ESSENTIAL TREMOR. WORLD NEUROSURGERY. 2012;78(5):554.E551-555. DOI: 10.1016/J.WNEU.2011.12.013. SUMMARY: TO EVALUATE THE EFFECTS OF REOPERATION WITH DEEP BRAIN STIMULATION (DBS) IN THE CAUDAL ZONA INCERTA (CZI) IN PATIENTS WITH FAILED DBS IN THE VENTRAL INTERMEDIATE (VIM) NUCLEUS OF THE THALAMUS FOR ESSENTIAL TREMOR. THE RESULTS OF REOPERATION WITH CZI DBS IN FIVE PATIENTS WITH FAILED VIM DBS WERE RETROSPECTIVELY ANALYZED. TWO PATIENTS HAD EARLY FAILURE OF VIM DBS, AND THREE AFTER SEVERAL YEARS OF GOOD EFFECT. THE MEAN DEVIATION FROM THE ATLAS VIM TARGET POINT WAS 1.4 MM. BEFORE THE REOPERATION VIM DBS IMPROVED HAND FUNCTION AND TREMOR IN THE TREATED HAND AT 25 %, WHEREAS CZI DBS ACHIEVED AN IMPROVEMENT OF 57%. ALTHOUGH CZI WAS MORE EFFICIENT THAN VIM DBS, ALSO IN THE PATIENTS WITH LATE FAILURE OF VIM DBS, THEY STILL EXHIBITED A CONSIDERABLE RESIDUAL TREMOR ON CZI DBS. THE EFFECT ON TREMOR WAS, IN THIS SMALL SAMPLE POPULATION, IMPROVED BY IMPLANTING AN ELECTRODE IN THE CZI. THE EFFECT WAS MODEST IN THOSE PATIENTS SUFFERING DETERIORATION YEARS AFTER THE INITIAL OPERATION. REPORTED EVENT: A (B)(6) MALE EXPERIENCED STIMULATION-INDUCED HEADACHE AND SENSORY SIDE EFFECTS FOLLOWING IMPLANT. THE SYSTEM WAS REMOVED. PRODUCT ANALYSIS WAS PERFORMED BY THE MANUFACTURER AND FOUND NO DEVICE ISSUE. THE PATIENT WAS REIMPLANTED IN THE LEFT CAUDAL ZONA INCERTA (CZI) AND TREMOR AND HAND FUNCTION WERE IMPROVED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ACTIVA STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN TREMOR MHY MEDTRONIC NEUROMODULATION NEU_INS_STIMULATOR

Patients

Seq Age Sex Outcome Treatment
1 00048 YR Required Intervention